Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis

We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled.

Detalles Bibliográficos
Autores principales: Kawaguchi, Yo, Hanaoka, Jun, Hayashi, Hideki, Fukuda, Yoshihisa, Iihara, Hirotoshi, Suzuki, Akio, Sugiyama, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044355/
https://www.ncbi.nlm.nih.gov/pubmed/32128186
http://dx.doi.org/10.1002/ccr3.2645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044355/
https://www.ncbi.nlm.nih.gov/pubmed/32128186
http://dx.doi.org/10.1002/ccr3.2645

Ejemplares similares